Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Biodesix financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.6
2024-10-29
Market Capitalization
$239.5 M
2024-10-29
Revenue
$88.5 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 03, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 54.5M | 38.2M | 49.1M | 71.3M | 88.5M |
| General and administrative expense | 50.5M | 61.5M | 67.4M | 80.5M | 87.5M |
| Operating expense total | 95.4M | 88.8M | 90.4M | 97.6M | 99.5M |
| EBIT | (40.9M) | (50.6M) | (41.3M) | (34.5M) | (27.9M) |
| EBIT margin, % | -75.1% | -132.4% | -84.2% | -48.4% | -31.5% |
| Interest expense | 4.5M | 8.1M | 9.5M | 8.3M | |
| Net Income | (43.2M) | (65.4M) | (52.1M) | (42.9M) | (35.3M) |
| EPS | (1.6) | (1.5) | (0.6) | (0.3) | (4.7) |